Department of Health written question – answered at on 30 March 2017.
To ask the Secretary of State for Health, if he will estimate the potential (a) medium and (b) long-term cost savings to the NHS of the use of genetic cascade testing to identify and treat familial hypercholesterolaemia.
The current National Institute for Health and Care Excellence guidance recommends genetic cascade testing for familial hypercholesterolaemia as highly cost effective. This guidance is currently under review, due to be issued in May 2017, and will take into account the latest changes to the costs of drugs and genetic tests in its revised economic modelling.
Yes2 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.